Further highlighting the importance of protein quality control, autosomal dominant mutations in RBM20 account for approximately 3% of DCM cases and can present with earlier-stage onset and greater severity than LMNA or TTN mutations.76 The gene discussed is RBM20; the disease is familial dilated cardiomyopathy.